Anixa Biosciences, Inc.
ANIX
$2.73
-$0.13-4.55%
| Weiss Ratings | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Weak | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.21 | |||
| Price History | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -13.33% | |||
| 30-Day Total Return | -13.06% | |||
| 60-Day Total Return | 17.67% | |||
| 90-Day Total Return | -11.36% | |||
| Year to Date Total Return | 15.19% | |||
| 1-Year Total Return | -18.51% | |||
| 2-Year Total Return | -41.29% | |||
| 3-Year Total Return | -1.97% | |||
| 5-Year Total Return | 68.52% | |||
| 52-Week High % Change | -29.29% | |||
| 52-Week Low % Change | 43.48% | |||
| Price | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $4.20 | |||
| 52-Week Low Price | $2.07 | |||
| 52-Week Low Price (Date) | Jan 14, 2025 | |||
| 52-Week High Price (Date) | Nov 08, 2024 | |||
| Valuation | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 95.62M | |||
| Enterprise Value | 77.45M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.39 | |||
| Earnings Per Share Growth | 12.75% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | 5.36 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $2.73 | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -5.69 | |||
| Market Cap Category | Micro Cap | |||
| Dividends and Shares | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 32.20M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 408 708 9808 | |||
| Address | 3150 Almaden Expressway San Jose, CA 95118 | |||
| Website | www.anixa.com | |||
| Country | United States | |||
| Year Founded | 1982 | |||
| Profitability | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -38.42% | |||
| Return on Equity | -- | |||
| Income Statement | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -- | |||
| EBIT (TTM) | -13.61M | |||
| Net Income (TTM) | -12.48M | |||
| Net Income Avl. to Common (TTM) | -12.48M | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 2.34% | |||
| EPS Diluted (TTM) | -0.39 | |||
| EPS Diluted Growth (Q YOY) | 4.44% | |||
| Balance Sheet | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 17.26M | |||
| Cash Per Share (Q) | $0.54 | |||
| Total Current Assets (Q) | 18.69M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 16.71M | |||
| Current Ratio (Q) | 9.348 | |||
| Book Value Per Share (Q) | $0.55 | |||
| Total Assets (Q) | 18.91M | |||
| Total Current Liabilities (Q) | 2.00M | |||
| Total Debt (Q) | 230.00K | |||
| Total Liabilities (Q) | 2.19M | |||
| Total Common Equity (Q) | 17.85M | |||
| Cash Flow | ANIX - NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | 6.85M | |||
| Cash from Financing (TTM) | 1.14M | |||
| Net Change in Cash (TTM) | 55.00K | |||
| Levered Free Cash Flow (TTM) | -3.39M | |||
| Cash from Operations (TTM) | -7.93M | |||
